Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Heike Püschel"'
Autor:
Cyrill A. Rentsch, Piet Bosshard, Grégoire Mayor, Malte Rieken, Heike Püschel, Grégory Wirth, Richard Cathomas, Gerald P. Parzmair, Leander Grode, Bernd Eisele, Hitt Sharma, Manish Gupta, Sunil Gairola, Umesh Shaligram, Daniel Goldenberger, François Spertini, Régine Audran, Milica Enoiu, Simona Berardi, Stefanie Hayoz, Andreas Wicki
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Background: VPM1002BC is a modified mycobacterium Bacillus Calmette Guérin (BCG) for the treatment of non-muscle invasive bladder cancer (NMIBC). The genetic modifications are expected to result in better immunogenicity and less side effects. We re
Externí odkaz:
https://doaj.org/article/435b8c0fec2b484c8e79c927de64db29
Autor:
Marc Matthias, Christian Wetterauer, Heike Püschel, Helge Seifert, Alexander Deckart, David Jean Winkel, Lukas Bubendorf, Daniel Boll, Elmar Merkle, Cyrill Rentsch
Publikováno v:
Journal of Urology. 209
Autor:
Cyrill A. Rentsch, George N. Thalmann, Ilaria Lucca, Maciej Kwiatkowski, Grégory J. Wirth, Räto T. Strebel, Daniel Engeler, Augusto Pedrazzini, Clemens Hüttenbrink, Wolfgang Schultze-Seemann, Raimund Torpai, Lukas Bubendorf, Andreas Wicki, Beat Roth, Piet Bosshard, Heike Püschel, Daniel T. Boll, Lukas Hefermehl, Florian Roghmann, Michael Gierth, Karin Ribi, Simon Schäfer, Stefanie Hayoz
BACKGROUND VPM1002BC is a genetically modified Mycobacterium bovis bacillus Calmette-Guérin (BCG) strain with potentially improved immunogenicity and attenuation. OBJECTIVE To report on the efficacy, safety, tolerability and quality of life of intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297c9a3fbb47508cf5a9f9f9d49b1e76
https://doi.org/10.5167/uzh-221992
https://doi.org/10.5167/uzh-221992
Autor:
M. Gierth, C. Hüttenbrink, A. Pedrazzini, Daniel T. Boll, R. Strebel, S. Schäfer, S. Hayoz, Grégory Johann Wirth, G. Thalmann, M. Kwiatkowski, F. Roghmann, Heike Püschel, A. Wicki, L. Hefermehl, P. Bosshard, I. Lucca, C.A. Rentsch, D. Engeler, W. Schultze-Seemann, B. Roth, Lukas Bubendorf
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e1183-e1184 (2020)
Autor:
Heike Püschel, Silke Gillessen, Christian Ruiz, Lukas Bubendorf, Thomas Hermanns, Ricardo Pereira Mestre, Jürgen Hench, Christian Rothermundt, Eloïse Kremer, Tatjana Vlajnic, Markus Tolnay, Natalie Fischer, Philippe von Burg, Richard Cathomas, Ivana Bratic Hench, W. Mingrone, Luigi Costa
Publikováno v:
Cancers, Vol 11, Iss 8, p 1099 (2019)
Cancers
Volume 11
Issue 8
Cancers
Volume 11
Issue 8
Despite several treatment options and an initial high response rate to androgen deprivation therapy, the majority of prostate cancers will eventually become castration-resistant in the metastatic stage (mCRPC). Androgen receptor splice variant 7 (ARV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3e2cd08ec8295b2c3a820620ec9070
https://www.zora.uzh.ch/id/eprint/181725/
https://www.zora.uzh.ch/id/eprint/181725/
Autor:
Georg Müller, Alexander Bachmann, Thomas C. Gasser, Gernot Bonkat, Cyrill A. Rentsch, Heike Püschel, Stephen Wyler, Lukas Bubendorf, Malte Rieken
Publikováno v:
Urology. 81:837-843
To compare the performance of the Epstein criteria and the Prostate Cancer Research International: Active Surveillance (PRIAS) criteria in the identification of patients eligible for active surveillance (AS) but treated with radical prostatectomy.We
Autor:
Nicole Ebinger Mundorff, Gernot Bonkat, Alexander Bachmann, Thomas C. Gasser, Heike Püschel, Georg Müller, Stephen Wyler, Malte Rieken
Publikováno v:
Lasers in Surgery and Medicine. 45:28-33
Background and Objective Preclinical studies suggest an increased vaporization rate and speed of the 532 nm 180-W XPS GreenLight laser (180-W) compared with the 120-W HPS GreenLight laser (120-W) and the 80-W PV GreenLight laser (80-W). To test the c
Autor:
Gernot Bonkat, Thomas Gasser, Malte Rieken, Georg Müller, Heike Püschel, Sanwei Guo, Alexander Bachmann
Publikováno v:
Journal of endourology. 29(4)
Laser vaporization of the prostate is one of the alternatives to transurethral resection of the prostate. Short-term studies report a comparable outcome after laser vaporization with the 532 nm 120-W GreenLight high-performance system (HPS) laser and
Autor:
Heike Püschel, Gernot Bonkat, Scherwin Talimi, Georg Müller, Malte Rieken, Alexander Bachmann, Kurt Lehmann, Sanwei Guo, Thomas C. Gasser
Publikováno v:
Lasers in medical science. 30(3)
This study aims to compare long-term results of photoselective vaporization of the prostate (PVP) with an 80-W potassium titanyl phosphate (KTP) laser and monopolar transurethral resection of the prostate (TURP) in terms of efficacy, durability, and
Autor:
M. Weibel, S. Bütikofer, Lukas Bubendorf, Heike Püschel, Tobias Zellweger, Cyrill A. Rentsch, Georg Müller, Joel R. Gsponer, Christian Wetterauer, Thomas C. Gasser, Tatjana Vlajnic, Alexander Bachmann
Publikováno v:
Virchows Archiv : an international journal of pathology. 465(6)
The reported incidental prostate cancer prevalence rates at radical cystoprostatectomy cover a range from 4 to 60 %. We investigated the influence of the histopathological work-up on prostate cancer prevalence rates. We identified 114 patients who ha